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Abstract
Airways hyperresponsiveness is a cardinal feature of asthma but remains unexplained. In asthma,
the airway smooth muscle cell is the key end-effector of bronchospasm and acute airway
narrowing, but in just the past five years our understanding of the relationship of responsiveness
to muscle biophysics has dramatically changed. It has become well established, for example, that
muscle length is equilibrated dynamically rather than statically, and that non-classical features of
muscle biophysics come to the forefront, including unanticipated interactions between the muscle
and its time-varying load, as well as the ability of the muscle cell to adapt rapidly to changes in its
dynamic microenvironment. These newly discovered phenomena have been described empirically,
but a mechanistic basis to explain them is only beginning to emerge.
Introduction
It is self-evident that acute narrowing of the asthmatic air-
way and shortening of the airway smooth muscle are inex-
tricably linked. Nonetheless, it was many years ago that
research on the asthmatic airway and research on the bio-
physics of airway smooth muscle (ASM) had a parting of
the ways [1]. The study of smooth muscle biophysics took
on a life of its own and pursued a deeply reductionist
agenda, one that became focused to a large extent on
myosin II and regulation of the acto-myosin cycling rate.
The study of airway biology pursued a reductionist agenda
as well, but one that became focused less and less on con-
tractile functions of muscle and instead emphasized
immune responses, inflammatory cells and mediators,
and, to the extent that smooth muscle remained of inter-
est, that interest centered mainly on synthetic, prolifera-
tive and migratory functions [2-7]. Inflammatory
remodeling of the airway wall was also recognized as
being a key event in the asthmatic diathesis [7-17]. Com-
putational models of ever increasing sophistication were
formulated in order to better understand the impact of
inflammatory remodeling processes upon ASM shorten-
ing and acute airway narrowing but, remarkably, the mus-
cle compartment of these models remained at a relatively
primitive level, being represented by nothing more than
the classical relationship of active isometric force vs. mus-
cle length [13,16,18-22]. As discussed below, this descrip-
tion is now considered to be problematic because the very
existence of a well-defined static force-length relationship
has of late been called into question, as has the classical
notion that the muscle possesses a well-defined optimal
length. Rather, other factors intrinsic to the muscle, espe-
cially muscle dynamics and mechanical plasticity, as well
as unanticipated interactions between the muscle and its
load, are now understood to be major factors affecting the
ability of the muscle to narrow the airway [1,23-27].
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The topics addressed in this review are intended to high-
light recent discoveries that bring airway biology and
smooth muscle biophysics into the same arena once
again. The emphasis is biophysical properties of airway
smooth muscle as they relate to excessive airway narrow-
ing. This is appropriate because, in the end, if airway
inflammation didn't cause airway narrowing, then
asthma might be a tolerable disease (Julian Solway, per-
sonal communication). But asthma is not a tolerable dis-
ease. In order to understand the multifaceted problem of
bronchospasm in asthma, therefore, an integrative under-
standing that brings together a diversity of factors will be
essential.
Airway hyperresponsiveness
It was recognized quite early that the lung is an irritable
organ and that stimulation of its contractile machinery in
an animal with an open chest can cause an increase in
lung recoil, air to be expelled, a rise in intratracheal pres-
sure, and an increase in airways resistance [28-31]. How-
ever, until the second half of the last century airway
smooth muscle was not regarded as being a tissue of any
particular significance in respiration mechanics [28]. A
notable exception in that regard was Salter [32], who, in
1859, was well aware of the existence of airway smooth
muscle and its potential role in asthma. Airway smooth
muscle was first described in 1804 by Reisseisen (as
related by Otis [28]) and its functional properties first
considered by Einthoven [33] and Dixon and Brodie [31].
More recent studies have shown that the fraction of the tis-
sue volume that is attributable to contractile machinery is
comparable for airways, alveolated ducts and blood ves-
sels in the lung parenchyma [34]; the lung parenchyma,
like the airway, is a contractile tissue [35-39]. Airway
smooth muscle is now recognized as being the major end-
effector of acute airway narrowing in asthma [18,21].
There is widespread agreement that shortening of airway
smooth muscle is the proximal cause of excessive airway
narrowing during an asthmatic attack [17], with swelling
of airway wall compartments and plugging by airway liq-
uid or mucous being important amplifying factors
[18,40]. It remains unclear, however, why in asthma the
muscle can shorten excessively.
Airway hyperresponsiveness is the term used to describe
airways that narrow too easily and too much in response
to challenge with nonspecific contractile agonists [41].
Typically, a graph of airways resistance vs. dose is sigmoid
in shape (Fig. 1); the response shows a plateau at high lev-
els of contractile stimulus. Generally, the existence of the
plateau is interpreted to mean that the airway smooth
muscle is activated maximally and, therefore, has short-
ened as much as it can against a given elastic load. Once
on the plateau, therefore, any further increase in stimulus
can produce no additional active force, muscle shorten-
ing, or airway resistance.
To say that airways narrow too easily, then, means that the
graph of airways resistance vs. dose of a non-specific con-
tractile stimulus is shifted to the left along the dose axis,
and that airways respond appreciably to levels of stimulus
at which the healthy individual would be unresponsive;
this phenomenon is called hypersensitivity. By contrast,
to say that the airways narrow too much means that the
level of the plateau response is elevated, or that the pla-
teau is abolished altogether, regardless of the position of
the curve along the dose-axis; this phenomenon is called
hyperreactivity. As distinct from hypersensitivity, it is this
ability of the airways to narrow excessively, with an ele-
vated or abolished plateau, that accounts for the morbid-
ity and mortality associated with asthma [42].
It has long been thought that the factors that cause hyper-
sensitivity vs. hyperreactivity are distinct, with the former
being associated with receptor complement and down-
stream signaling events but the latter being associated
with purely mechanical factors, including the contractile
apparatus, the cytoskeleton, and the mechanical load
against which the muscle shortens [16,18,21,43]. Mack-
lem has pointed out that once the muscle has become
maximally activated it is the active force and the load that
become all important, and the plateau response becomes
essentially uncoupled from underlying biochemistry, sig-
naling and cell biology [20-22]. As described below, there
is reason to think that these distinctions may not be as
clear as once believed, however.
Although asthma is usually defined as being an inflamma-
tory disease, the link between the immunological pheno-
type and the resulting mechanical phenotype associated
with disease presentation, including airways hyperrespon-
siveness, remains unclear; indeed, it is now established
that airway hyperresponsiveness can be uncoupled from
airway inflammation [44-47]. It remains equally unclear
if airway hyperresponsiveness is due to fundamental
changes within the smooth muscle itself, as might be
caused by inflammatory mediators, chemokines and
cytokines [48], or due to changes external to the muscle
such as a reduced mechanical load against which the
smooth muscle contracts. Still another possibility sup-
ported by recent evidence is that there is an interaction of
the two wherein the contractile machinery within the
smooth muscle cell adapts in response to a change in its
mechanical microenvironment [1,17,24,25,27,49,50].
Moreover, Tschumperlin and colleagues [51,52] have pro-
vided evidence to suggest that bronchospasm can lead to
mechanically-transduced pro-inflammatory signaling
events in the airway epithelium, in which caseRespiratory Research 2004, 5 http://respiratory-research.com/content/5/1/2
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inflammation may cause bronchospasm, but bronchos-
pasm in turn may amplify or even cause inflammation.
In the balance of this review I address the classical picture
of smooth muscle behavior and then go on to describe
what we know about non-classical behavior in a dynamic
mechanical environment driven by the tidal action of
breathing. In addition, in recent years we have come to
learn that the mechanical environment leads to interest-
ing airway instabilities and adaptation in the muscle itself.
Finally, I conclude by providing an emerging integrative
context that seems to account for many of these properties
that are not accounted for in classical perspectives of
smooth muscle biophysics. I do not address the increasing
evidence that now suggests that cytokines such as IL-1β
and TNFα augment responses to bronchoconstrictor ago-
nists while attenuating the bronchodilation that can be
effected by hormones and paracrine agents like epine-
phrine and PGE2 [53]. Such cytokines, along with growth
factors and other inflammatory mediators also result in
smooth muscle hyperplasia, at least in culture systems [5].
In culture, extracellular matrix proteins also influence the
contractile phenotype of airway smooth muscle cells
[54,55]. Whether asthmatic inflammation can result in a
hypercontractile phenotype remains to be established.
A computational result showing airway length (top) and airway resistance (bottom) as a function of agonist concentration for a  tenth generation airway [151] Figure 1
A computational result showing airway length (top) and airway resistance (bottom) as a function of agonist concentration for a 
tenth generation airway [151]. The cases shown depict airways from a normal, an asthmatic and a COPD lung. In this compu-
tation, the effects of tidal breathing and deep inspirations (6/minute) upon myosin binding dynamics are taken into account 
explicitly [151]. As explained in the text, such an airway exhibits both hyperreactivity and hypersensitivity.
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Classical behavior of airway smooth muscle and 
the balance of static forces
The microstructure of striated muscle is highly ordered
whereas there is abundant evidence in the literature dem-
onstrating that the cytoskeletal matrix of smooth muscle
is quite disordered [56,57]; it is, after all, its amorphous
structure that gives 'smooth' muscle its name. Moreover,
the cytoskeletal matrix of airway smooth muscle is in a
continuous state of remodeling, a point to which we
return below. Despite these differences, it has been widely
presumed that to a first approximation Huxley's sliding
filament model of muscle contraction [58] describes the
function of both smooth and striated muscle [59-61]. For
many of the biophysical phenomena observed in airway
smooth muscle, such as active force generation and short-
ening velocity, Huxley's model represents a useful tool for
thought [61], while for others, like mechanical plasticity,
it does not.
As in the case of striated muscle contraction, the principal
biophysical parameters that characterize the case of
smooth muscle contraction include the maximum active
isometric force (or stress, which is simply the force carried
per unit area), the length at which the muscle can attain
that maximal force (i.e., the optimum length, Lo), and the
shortening capacity of the muscle. The sliding filament
model of Huxley is the starting point for understanding
each of these phenomena. As described by Huxley [58],
isometric force, as well as muscle stiffness, are propor-
tional to the number of acto-myosin cross links per unit
volume. This is true because, assuming rigid filaments, all
bridges within a given contractile unit must act mechani-
cally in parallel, with their displacements being identical
and their forces being additive. The maximum active stress
supported by smooth vs. striated muscle is approximately
the same and is of the order 105 Pascal. In striated muscle,
the optimum length is attributed to the extent of overlap
between the myosin filament and the actin filament, with
optimum length corresponding to a maximum number of
myosin heads finding themselves within striking distance
of an available actin binding site, and the maximum
capacity of the muscle to shorten being limited by the col-
lision of the myosin filament end with the z-disc. Smooth
muscle possesses no structure comparable to the z-disc,
however, although actin filaments terminate in dense
bodies, which might come into play in limiting muscle
shortening. Whereas unloaded striated muscle can
shorten perhaps 20% from its optimum length, unloaded
smooth muscle can shorten as much as 70% [62-65]. Sev-
eral physical factors may come into play to limit the
capacity for unloaded shortening of smooth muscle.
Small [56,57] has shown that the actin filaments of the
contractile apparatus connect to the cytoskeleton at cyto-
plasmic dense bodies and with the longitudinal rib-like
arrays of dense plaques of the membrane skeleton that
couple to the extracellular matrix. Moreover, the side-
polar configuration of the myosin filament [66,67] is
likely to be involved. Still other factors coming into play
include length-dependent activation [68,69], length-
dependent rearrangements of the cytoskeleton and con-
tractile machinery [27,70], and length-dependent internal
loads [65,71,72].
What are the extramuscular factors that act to limit airway
smooth muscle shortening? The basic notion, of course, is
that muscle shortening stops when the total force gener-
ated by the muscle comes into a static balance with the
load against which the muscle has shortened, both of
which vary with muscle length. The factors setting the
load include the elasticity of the airway wall, elastic teth-
ering forces conferred by the surrounding lung paren-
chyma, active tethering forces conferred by contractile
cells in the lung parenchyma [73,74], mechanical cou-
pling of the airway to the parenchyma by the peribron-
chial adventitia, and buckling of the airway epithelium
and submucosa [75-77]. In addition, the airway smooth
muscle itself is a syncytium comprised mostly of smooth
muscle cells, aligned roughly along the axis of muscle
shortening, and held together by an intercellular connec-
tive tissue network. In order to conserve volume, as the
muscle shortens it must also thicken. And as the muscle
shortens and thickens, the intercellular connective tissue
network must distort accordingly. Meiss has shown evi-
dence to suggest that at the extremes of muscle shortening
it may be the loads associated with radial expansion (rel-
ative to the axis of muscle shortening) of the intercellular
connective tissue network that limits the ability of the
muscle to shorten further [78].
In the healthy intact dog, airway smooth muscle possesses
sufficient force generating capacity to close all airways
[79,80]. This fact may at first seem to be unremarkable,
but it is not easily reconciled with the observation that
when healthy animals or humans are challenged with
inhaled contractile agonists in concentrations thought to
be sufficient to activate the muscle maximally, resulting
airway narrowing is limited in extent, and that limit falls
far short of airway closure [81,82]. Breathing remains
unaccountably easy. Indeed, it is this lightness of breath-
ing in the healthy challenged lung, rather than the labored
breathing that is characteristic of the asthmatic lung, that
in many ways presents the greater challenge to our under-
standing of the determinants of acute airway narrowing
[83]. Brown and Mitzner [79] have suggested that the pla-
teau of the dose-response curve reflects uneven or limited
aerosol delivery to the airways. Another possibility, how-
ever, is that mechanisms exist that act to limit the extent
of muscle shortening in the healthy breathing lung,
whereas these mechanisms become compromised in the
asthmatic lung. It has been suspected that the impairmentRespiratory Research 2004, 5 http://respiratory-research.com/content/5/1/2
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of that salutary mechanism, if it could only be under-
stood, might help to unlock some of the secrets surround-
ing excessive airway narrowing in asthma, as well as the
morbidity and mortality associated with that disease [84-
87]. This brings us to muscle dynamics, deep inspirations,
and the potent effects of a time-varying muscle load asso-
ciated with the act of breathing.
Shortening velocity and other manifestations of 
muscle dynamics
The oldest and certainly the simplest explanation of air-
way hyperreactivity would be that muscle from the asth-
matic airway is stronger than muscle from the healthy
airway, but evidence in support of that hypothesis
remains equivocal [3,4,88]. Indeed, studies from the lab-
oratory of Stephens and colleagues [26,89-91] have
emphasized that the force generation capacity of allergen-
sensitized airway smooth muscle of the dog, or asthmatic
muscle from the human, is no different from that of con-
trol muscle. As a result, the search for an explanation
turned to other factors, and several alternative hypotheses
have been advanced. These fall into three broad classes,
each of which is consistent with remodeling events
induced by the inflammatory microenvironment, and
include an increase of muscle mass [13,77,92], a decrease
of the static load against which the muscle shortens
[13,75,77,92], and a decrease of the fluctuating load that
perturbs myosin binding during breathing, described in
greater detail below [23,24,93,94]. Aside from their effects
on acto-myosin binding, changes in the static load and/or
the dynamic load also lead to dramatic cytoskeletal
remodeling events as the smooth muscle cell adapts to its
microenvironment. Together, these hypotheses are attrac-
tive because they suggest a variety of mechanisms by
which airway smooth muscle can shorten excessively even
while the isometric force generating capacity of the muscle
remains essentially unchanged.
Setting the muscle length: a process equilibrated statically 
or dynamically?
Even if the force generating capacity is unchanged, a con-
sistent association has been noted between airway hyper-
responsiveness and unloaded shortening velocity of the
muscle [89,90,95-97]. This association suggests the possi-
bility that the problem with airway smooth muscle in
asthma may be that it is too fast rather than too strong.
But how shortening velocity – a dynamic property of the
muscle – might cause excessive airway narrowing – a
parameter that was thought to be determined by a balance
of static forces – remains unclear. To account for increased
shortening capacity of unloaded cells, Stephens and col-
leagues have reasoned that upon activation virtually all
muscle shortening is completed within the first few sec-
onds [97]. As such, the faster the muscle can shorten
within this limited time window, the more it will shorten.
However, in isotonic loading conditions at physiological
levels of load, muscle shortening is indeed most rapid at
the very beginning of the contraction, but appreciable
shortening continues for at least 10 min after the onset of
the contractile stimulus [24]. An alternative hypothesis to
explain why intrinsically faster muscle might shorten
more comes from consideration of the temporal fluctua-
tions of the muscle load that are attributable to the action
of spontaneous breathing [24,88,98]}. Load fluctuations
that are attendant to spontaneous breathing are the most
potent of all known bronchodilating agencies [99,100].
Among many possible effects, these load fluctuations per-
turb the binding of myosin to actin, causing the myosin
head to detach from actin much sooner than it would
have during an isometric contraction. But the faster the
myosin cycling (i.e., the faster the muscle), the more diffi-
cult it is for imposed load fluctuations to perturb the acto-
myosin reaction. This is because the faster the intrinsic
rate of cycling, the faster will a bridge, once becoming
detached, reattach and contribute once again to active
force and stiffness.
Why is muscle from the allergen sensitized animal or asth-
matic subject faster? For technical reasons, in their study
on biopsy specimens from asthmatic subjects Ma et al [97]
did not measure expression of myosin light chain kinase,
but their finding of increased content of message strongly
implicates MLCK. Although regulation of myosin phos-
phorylation is a complex process with multiple kinase and
phosphatase pathways, this finding substantially narrows
the search for the culprit that may account for the
mechanical changes observed in these cells. Also, these
studies seem to rule out changes in the distribution of
myosin heavy chain isoforms; content and isoform distri-
butions of message from asthmatic cells showed the pres-
ence of smooth muscle myosin heavy chain A (SM-A) but
not SM-B, the latter of which contains a seven-amino acid
insert, is typical of phasic rather than tonic smooth mus-
cle, and is by far the faster of the two isoforms [101,102].
Together, these findings confirm in muscle biopsy speci-
mens from the asthmatic airway a number of findings
from the allergen-sensitized dog model.
Cycling rate regulation
In smooth muscle, shortening velocity and its determi-
nants are of particular interest [60,103]. Compared to stri-
ated muscle, the maximum unloaded shortening velocity
of smooth muscle is smaller by more than an order of
magnitude. This difference seems to be a adaptation to
smooth muscle functions; whereas striated muscles typi-
cally produce motion or work in an efficient manner (i.e.,
converting chemical energy into mechanical energy with a
small amount of energy lost to heat), smooth muscles are
found in hollow organs where they serve to maintain tone
or shape in an economical manner (i.e., doing so at a rateRespiratory Research 2004, 5 http://respiratory-research.com/content/5/1/2
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of chemical energy utilization that is smaller than that
consumed striated muscle by about 300 fold [59,60].
Since the rate of myosin ATPase activity is tied directly to
the myosin cyclic rate [104,105], a slower cycling rate
implies economical maintenance of tone.
If smooth muscle is activated but held isometrically as the
waiting time between the stimulus onset and a subse-
quent quick release is increased, the isometric force grows
but the rate of ATP utilization and unloaded shortening
velocity immediately after the release progressively
decrease; this curious behavior represents a major distinc-
tion between smooth and striated muscle. Huxley's view
of muscle contraction implies that the unloaded shorten-
ing velocity is set by the rate at which the myosin head can
advance along the actin filament. Accordingly, for a given
myosin step size, this means that shortening velocity is a
direct measure of cross bridge cycling rate. Since the short-
ening velocity is found to decrease appreciably with
increasing waiting time, the logical explanation following
these ideas is that the cycling rate is a regulated variable
and decreases as a function of time since the onset of the
activation. Taken together, force maintenance, down-reg-
ulation of unloaded shortening velocity, and reduced
rates of ATP utilization, comprise what is known as the
latch state, or, equivalently, the latch phenomenon.
Latch
Force generated by any smooth muscle is sustained by
cyclic interactions of myosin with actin. With onset of the
contractile event, myosin-actin cycling begins and the
number of interactions (bridges) increases and eventually
approaches a steady state. It is widely agreed that during
this process the rate of bridge cycling initially increases
but then becomes substantially diminished. The mecha-
nisms of cycling rate regulation remain very much an
open question in the literature [103,106-113].
Among mechanisms of cycling rate regulation that have
been proposed, the foremost is the latch hypothesis of Hai
and Murphy, which has the attributes of being the sim-
plest and capturing the central importance of phosphor-
ylation of the 20 kDa myosin regulatory light chain
[103,106,114-116]. Murphy and his colleagues suggested
that the latch phenomenon arises as rapidly cycling cross
bridges are replaced progressively by slowly cycling latch
bridges if given enough time at a fixed muscle length,
where the latch bridge is nothing more than a myosin
head whose 20 kDa regulatory light chain becomes
dephosphorylated while remaining attached to actin and
maintaining both force and stiffness. The central notion is
that the latch bridge has a very small rate of detachment
from actin and, as a result, the latch bridge comprises an
internal load against which rapidly cycling bridges must
shorten [61].
Within the latch schema, the attainment of the isometric
steady state implies that the population distribution of
myosin molecules among their four possible states
(attached vs. unattached to actin, phosphorylated vs.
unphosphorylated regulatory light chains) have come to a
binding equilibrium set by a balance of kinetic rate proc-
esses, many of which are ATP dependent. Once enough
time has passed that this balance is attained and myosin
has come to a binding equilibrium appropriate to isomet-
ric steady-state conditions, the muscle is then said to be in
the latch state. Thus, the latch state corresponds to what I
will refer to as a static equilibrium of myosin binding at
the molecular level, and a balance of static forces at the
mechanical level.
Whether the latch bridge might account for the latch phe-
nomenon remains a point of some contention, however.
The accessory proteins calponin and caldesmon are
known to modulate the rate of muscle shortening, and
have been suggested as being molecules responsible for or
contributing to the latch phenomenon, but the mecha-
nisms of action of these molecules are not well under-
stood [108,117-119]. Finally, if contractile units were
evanescent and the number of such units in series were to
decrease progressively during a contractile event, as dis-
cussed below, it has been suggested that these adaptations
might account for the latch phenomenon [25].
Non-classical behavior: load fluctuations and 
dynamic equilibration of the muscle length
Load fluctuations are imposed continuously on airway
smooth muscle and pulmonary vascular smooth muscle
by the tidal action of breathing, and on muscular systemic
arteries and arterioles by the pulsatile action of blood
ejected from the heart. Smooth muscles in the urethra,
urinary bladder, and gut are also subjected to periodic
stretch. Accordingly, imposed fluctuations in muscle load
seem to be a universal part of smooth muscle physiology.
It is well established that imposition of load fluctuations
on smooth muscle inhibits development of active force
and stiffness [80,98,120]. Although imposed load fluctu-
ations induce important plastic changes in the cytoskele-
ton, as described later in this review [27,70], a major part
of the force and stiffness inhibitions that are observed are
attributable to direct effects of tidal stretch upon bridge
dynamics [24,61,98].
Perturbed equilibria of myosin binding
In the case of airway smooth muscle, the effects of oscilla-
tory loading were first addressed by Sasaki and Hoppin
and later by Gunst and colleagues, who demonstrated that
imposition of tidal changes in muscle length depresses
active force [98,120-123]. Subsequent studies [24,98]
showed that imposed fluctuations of muscle length aboutRespiratory Research 2004, 5 http://respiratory-research.com/content/5/1/2
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a fixed mean length cause depression of muscle force and
muscle stiffness (averaged over the stretch cycle); imposed
length fluctuations also cause augmentation of the spe-
cific rate of ATP utilization and the hysteresivity (related
to the muscle viscosity and an index of bridge cycling rate,
as described below [105]. Thus, from both a mechanical
and a metabolic point of view, the perturbed state is a hot
or a melted state of the muscle [23,24,61,94]. Imposed
force fluctuations about a fixed mean distending force sys-
tematically bias the airway smooth muscle toward length-
ening; this phenomenon is called fluctuation-driven
muscle lengthening [24]. Although tidal stretches smaller
than 1% of muscle length produce only trivial mechanical
effects, tidal stretches in the range of amplitudes expected
during quiet tidal breathing (about 3% of muscle length)
produce force inhibition that is equipotent with concen-
trations of isoproterenol in the range 10-7 to 10-5 M [99].
Molfino et al. showed in humans that brief cessation of
tidal breathing causes the cross-sectional area of central
airways to decrease by about half under the influence of
baseline smooth muscle tone, and when tidal breathing is
resumed the airway promptly dilates [124]. Taken
together, these findings suggest that quiet tidal breathing
is as effective in relaxing airway smooth muscle as is a
potent relaxing agonist.
Importantly, there is increasing evidence that the potent
bronchodilating response to periodic stretch and deep
inspirations is impaired in asthma, and that this impair-
ment may be the proximal cause of the loss of the plateau
of the dose-response curve and the resulting morbidity of
the disease [81,84,86,87,125,126]. There exists also a
bronchoprotective effect of deep inspirations; deep inspi-
rations prior to agonist challenge have been shown to
blunt the subsequent contractile response [127-131]. It
has been suggested that the bronchoprotective effect of
deep inspirations are even more important than the bron-
chodilating response, and it too is profoundly impaired in
asthma.
Lung inflations strain airway smooth muscle with each
breath, and these periodic mechanical strains are trans-
mitted to the myosin head and cause it to detach from the
actin filament much sooner than it would have in isomet-
ric circumstances. This premature detachment profoundly
reduces the duty cycle of myosin, typically by as much as
50–80% of its unperturbed isometric steady-state value,
and depresses total numbers of bridges attached and
active force to a similar extent. Of the full isometric force
generating capacity of the muscle, therefore, only a small
fraction ever comes to bear on the airway during tidal
breathing, even when the muscle is activated maximally.
Since bridge cycling is strongly perturbed by the imposed
tidal stretches over time the number of myosin attach-
ment and detachment events come into a dynamic bal-
ance. To distinguish it from the state that prevails in static
loading conditions, this state has been called a perturbed
equilibrium of myosin binding [24,61].
In pathological circumstances the tidal strains acting on
myosin can become compromised, however. For exam-
ple, in the chronically inflamed airway the peribronchial
adventitia thickens [8,9,132]; this thickening decreases
tidal muscle strains and thereby permits myosin binding
to approach an unperturbed binding equilibrium. In
doing so, the muscle would then generate the full comple-
ment of isometric force appropriate to the stimulus. Any
factor that lessens peribronchial stress will decrease the
force fluctuations impinging upon the muscle, including
inflammatory thickening of the lamina reticulosa, thick-
ening of the peribronchial adventitia, loss of lung elastic
recoil, breathing at low lung volumes, and failure to take
deep breaths [18,21,22,75,133-135]; in addition, Cole-
batch and colleagues found evidence of increased rigidity
of airways in asthmatic subjects [136]. If any of these fac-
tors pertain, then the perturbed equilibrium of myosin
binding can collapse toward a static binding equilibrium.
For example, if for any reason the muscle should stretch a
bit less, then fewer bridges would be perturbed. Because
more attached bridges working in parallel are harder to
break than fewer, the muscle would then become stiffer
still and therefore stretch even less, and so on. Ultimately
this process reaches the limit in which the muscle may
become so stiff that the physiological forces acting on it
are insufficient to stretch the muscle appreciably, leaving
the muscle stuck at its static equilibrium length
[23,24,61]. Compared with the perturbed state, this stati-
cally equilibrated contractile state is also characterized by
slow bridge cycling and a small rate of ATP utilization per
bridge attached or per unit force developed [24]. So from
both the mechanical and the metabolic point of view, it
would appear to be a cold or 'frozen' contractile state. The
muscle could be said to be statically equilibrated and fro-
zen in the latch state.
This point of view leads to the hypothesis that airway
hyperresponsiveness is associated with the failure of the
underlying perturbed binding equilibrium to sustain
itself, and an ensuing collapse of myosin binding kinetics
to the binding equilibrium that pertains in static condi-
tions and latch [23]. Clearly, this constellation of factors
points towards dynamic instability, as described below.
Dynamic muscle instabilities
It is a well-established empirical fact that within any given
lung or lung segment the response of airways to contrac-
tile agonists is always accompanied by 1) extreme hetero-
geneity of the response and 2) sensitivity of the response
to the amplitude of the tidal volume and the magnitude
of the load fluctuation [36,100,137-142]. It has beenRespiratory Research 2004, 5 http://respiratory-research.com/content/5/1/2
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speculated that the observation of a smoothly graded
decline of tests of lung functions (such as lung resistance)
with progressively increasing doses of contractile agonist
might be better explained by progressive changes in
number of open airways accommodating gas flow rather
than by some smoothly changing reduction in the airway
caliber of each [138]. Indeed, the heterogeneity of the
response is so extensive that peripheral airways have
sometimes been thought of as being partitioned into only
two quantum-like states, as it were, either open wide or
almost closed entirely, with virtually no intermediate state
[138,143,144]. Several plausible factors have been
invoked to try to account for this profound heterogeneity
of the contractile response, including intrinsic inhomoge-
neities in airway structure, muscle amounts, muscle sensi-
tivity to agonist, and nonuniformity of agonist delivery
[36,79,145].
Anafi and Wilson considered the narrowing of an airway
containing activated airway smooth muscle subject to
load fluctuations as would occur during breathing
[146,147]. Their mathematical analysis shows that in
some circumstances such an airway must become unsta-
ble. Of course, the generic idea that airways can be unsta-
ble is not at all new [148], but the analysis of Anafi and
Wilson identified a new class of airway instability that is
intrinsically dynamic and, in particular, is rooted in the
response of airway smooth muscle to imposed load
fluctuations.
To appreciate the potential importance of this muscle
instability, we imagine a lung in which there are a large
number of airways that are all operating in parallel and
that are in every regard identical. The airway smooth mus-
cle is activated uniformly and subjected to identical load
fluctuations caused by the tidal action of breathing. Even
though inter-regional differences are infinitesimally small
at the outset, any small perturbation would be amplified
by the processes described above. And as the differences
grow the amplification grows. When the process eventu-
ally becomes dynamically equilibrated, the airways will
be seen to have partitioned themselves between only two
states in order to accommodate the total flow-one state
effectively wide open and the other nearly closed. The
analysis of Anafi and Wilson and that of Fredberg and col-
leagues [24] address overlapping but different aspects of
airway narrowing; although the relationship between
these perspectives remains somewhat unclear, airway
smooth muscle in the closed airways might be expected to
correspond to the static or 'frozen' state, and muscle in the
open airways might be expected to correspond to a
'melted' state with an underlying perturbed equilibrium
of myosin binding. Changes in tidal volume would affect
the number of airways in each state.
In the healthy lung during spontaneous breathing, tidal
volume and associated force fluctuations acting on airway
smooth muscle may be large enough to keep almost all
units in the open/melted state and out of jeopardy of clo-
sure. But if tidal volumes were compromised, or deep
inspirations were prohibited, or transmission of force
fluctuations to the airway smooth muscle were to become
compromised, then a larger fraction of units would be
expected to be found in the closed/frozen state. Therefore,
this picture would seem to be able to explain in one stroke
both a profound heterogeneity of the airway response and
its sensitivity to tidal volume.
This insight on instability of smooth muscle dynamics
does not preclude important contributions from intrinsic
heterogeneities that exist amongst airways, of course. The
Anafi-Wilson instability is attractive, though, because it
shows that it is not necessary to postulate intrinsic airway
heterogeneity of any kind in order to account for both a
profound heterogeneity of the airway response and its
sensitivity to tidal volume.
Deep Inspirations
Jensen and colleagues [149] followed the earlier studies of
Fish [84], Lim et al. [86], and then Skloot [87] to show in
normal individuals challenged with nonspecific contrac-
tile agonists that a single deep inspiration (DI) causes a
prompt and dramatic decrease in airway resistance (Raw)
followed by a slow return of Raw to the level observed
prior to the DI. By contrast, in individuals with severe
asthma a single DI causes a prompt but only modest
decrease in Raw followed by rapid return of Raw to the
level observed prior to the DI. The findings in challenged
normal individuals are consistent with disruption of cross
bridges as described above. In the asthmatic, however, it
is plausible that bridges were stretched, but not enough to
disrupt an appreciable fraction of the acto-myosin bonds.
Immediately following the deep inspiration, the rapid
recovery of Raw to pre-DI levels could reflect either a rapid
elastic recoil of the stretched muscle, or an altered
cytoskeletal remodeling response to the DI (described
below), or reattachment of bridges that were disrupted,
but at a rate that is faster than that observed in healthy
individuals.
The crucial role of tidal loading of the ASM was further
demonstrated by Mitzner and Brown in an ingenious use
of high resolution CT in a dog model in which one lung
was ventilated while the other was held isovolumic [150].
Compared to the lung undergoing cyclic volume changes,
the isovolumic hung was found to be both hyperrespon-
sive and refractory to the bronchodilating effects of a sub-
sequent deep inspiration.Respiratory Research 2004, 5 http://respiratory-research.com/content/5/1/2
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In order to better understand these processes and, espe-
cially, the impact of inflammatory remodeling processes
upon ASM shortening and acute airway narrowing, Mijail-
ovich and colleagues [151] developed a computational
model which, unlike previous attempts [13,16,21], took
into account explicitly molecular dynamics of myosin and
the ability of load fluctuations associated with tidal
breathing and periodic deep inspirations to perturb
myosin binding. Results for a generation 10 airway reveal
hyperreactive airways in asthma and COPD, as was found
by others using static muscle models (Fig. 1). However,
this model of molecular dynamics expresses two addi-
tional phenomena that the static model does not. The first
is induction of hypersensitivity – a shift of the dose-
response curve to the left – which arises from myosin
binding dynamics and their interaction with a fluctuating
load. As noted above, mechanisms responsible for hyper-
sensitivity vs. hyperreactivity had been though to be dis-
tinct whereas, by contrast, this result shows that myosin
binding dynamics in the setting of a fluctuating mechani-
cal load can elicit both. Compared to the case of the asth-
matic airway, in the case of the normal airway the action
of tidal loading upon myosin binding dynamics is suffi-
cient to inhibit airway narrowing until the level of muscle
activation is relatively large. The second phenomenon is
what would appear to be a discontinuous or unstable
response: with an increasing degree of muscle activation
(agonist dose) there arises a value beyond which, when
the airway does begin to narrow, it does so precipitously.
Taken together, these non-classical behaviors support the
notion that activated airway smooth muscle is typically
melted by the tidal action of breathing and, therefore,
muscle length is dynamically equilibrated. Nonetheless,
in pathological circumstances, as described below, muscle
can become frozen in the latch state.
Clinical manifestations
In practical terms, specific instances in which elevated
rates of bridge cycling might come into play include the
differences in airway responsiveness that have been
observed between normal versus allergen sensitized mus-
cle, between certain animal strains and, in some species,
between mature versus immature animals [68,142,152-
156]. This rationale leads us to a plausible mechanism by
which the rate of bridge cycling and its regulation may be
reasonably thought to bear upon the prevalence of child-
hood asthma and its changes with lung maturation and
allergic status.
Although far from explaining these phenomena in their
entirety, the perturbed equilibrium hypothesis may help
to tie together still other loose ends (Fig. 2). According to
that hypothesis, greater contractile responses are favored
whenever the force fluctuations acting on the airway
become compromised, not only when the peribronchial
adventitia undergoes cytokine-driven inflammatory thick-
ening, but also when the lung loses elastic recoil, or tidal
lung expansion becomes diminished. These instances
bring immediately to mind not only asthma, but also
emphysema, normative aging, restrictive disorders of the
chest wall, obesity, and cervical spinal cord injury, each of
which is known to be associated with a predisposition for
airway hyperresponsiveness or asthma [157-163].
Reduced amplitude of force fluctuations may come into
play similarly in asthma exacerbations that occur during
sleep (nocturnal asthma) [164,165] and during late preg-
nancy [166,167] where, in both circumstances, functional
residual capacities are diminished [168,169], suggesting
in turn diminished lung recoil and smaller load fluctua-
tions acting upon the airway smooth muscle [24,94].
Moreover, it is clear that when inflammatory remodeling
of the airway does occur, the perturbed equilibrium
hypothesis predicts that the resulting predisposition for
airway hyperresponsiveness might persist long after the
inflammation itself is resolved [46,170]. And finally, per-
turbed equilibria might also help to explain why the
obstructive response in exercise-induced asthma typically
begins only after cessation of the exercise, when tidal vol-
umes have declined to resting levels.
Mechanical plasticity: another non-classical 
feature of airway smooth muscle
When activated muscle in the muscle bath is subjected to
progressively increasing load fluctuations approaching
the magnitude and frequency expected during normal
breathing, the muscle lengthens appreciably in response
[24]. But when load fluctuations are progressively
reduced, the muscle reshortens somewhat but fails to
return to its original length. Incomplete reshortening after
exposure to tidal loading is not accounted for by muscle
injury; the original operating length can be recovered sim-
ply by removing the contractile agonist and allowing the
muscle a short interval before recontracting. Neither can
incomplete reshortening be accounted for by myosin
dynamics; myosin dynamics by themselves predict com-
plete reshortening when the load fluctuations are
removed [24]. Thus, the failure of activated muscle to
reshorten completely is evidence of a plasticity of the con-
tractile response. During a sustained contraction, the
operational length of the muscle for a given loading, or
the force at a given length, can be reset by loading and the
history of that loading [1,24,25,27,49,70,171-174]. In
healthy individuals this plasticity seems to work in a favo-
rable direction, allowing activated muscle to be reset to a
longer length. The asthmatic, it has been argued, never
manages to melt the contractile domain in the airway
smooth muscle and, as such, the benefits of this plastic
response are not attained.Respiratory Research 2004, 5 http://respiratory-research.com/content/5/1/2
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It is now firmly established that airway smooth muscle
can somehow adapt its contractile machinery, as well as
the cytoskeletal scaffolding on which that machinery
operates, in such a way that the muscle can maintain the
same high force over an extraordinary range of muscle
length [1,24,25,27,70,173-178]; ASM is characterized by
its ability to disassemble its contractile apparatus when an
appropriate stimulus is given, and its ability to reassemble
that apparatus when accommodated at a fixed length.
When exposed to contractile agonists, airway smooth
muscle cells in culture reorganize cytoskeletal polymers,
especially actin [179], and become stiffer [180]. Although
cell stiffening is attributable largely to activation of the
contractile machinery, an intact actin lattice has been
shown to be necessary but not sufficient to account for the
stiffening response [180].
The perturbed equilibrium hypothesis connects phenotypes that were largely unexplained and had been thought to be essen- tially unrelated Figure 2
The perturbed equilibrium hypothesis connects phenotypes that were largely unexplained and had been thought to be essen-
tially unrelated. Reduced force fluctuations and/or increased bridge cycling rates allow airway smooth muscle to more nearly 
approach a static equilibrium of myosin binding (latch) and the frozen state. Airway hyperresponsiveness phenotypes shown in 
blue correspond to circumstances in which the airway and airway smooth muscle might be normal but there is a problem with 
the respiratory pump, i.e., the muscles of the chest wall. Those shown purples correspond to phenotypes in which the airway 
smooth muscle may be normal, but there is a problem in the mechanical coupling between the respiratory pump and the 
myosin motor. Finally, those shown in green correspond to phenotypes in which the problem may be at the level of the myosin 
motor itself. At that level, the rate of bridge cycling is thought to be influenced by its isoform, the amount of myosin light chain 
kinase, caldesmon, calponin, Rho-kinase and other factors.
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Malleability of the cell and its mechanical consequences
have been called by various authors mechanical plasticity,
remodeling, accommodation or adaptation. Even though
the force generating capacity varies little with length in the
fully adapted muscle, the unloaded shortening velocity
and the muscle compliance vary with muscle length in
such a way as to suggest that the muscle cell adapts by
adding or subtracting contractile units that are mechani-
cally in series. The mechanisms by which these changes
come about and the factors that control the rate of plastic
adaptation are unknown, however.
Several hypotheses have been advanced to explain
smooth muscle plasticity. Ford and colleagues have sug-
gested that the architecture of the myosin fibers them-
selves may change [27], while Gunst and colleagues have
argued that it is the connection of the actin filament to the
focal adhesion plaque at the cell boundary that is influ-
enced by loading history [70,171,172]. Alternatively,
another notion is that secondary but important molecules
stabilize the cytoskeleton, and as the contractile domain
melts under the influence of imposed load fluctuations,
those loads must be borne increasingly by the scaffolding
itself, and thus reflects malleability of the cytoskeletal
domain [23,54,70,181]. In that connection a role for the
Rho-A pathway has been suggested [54,182] and some
evidence now suggests that the p38 MAP kinase pathway
may be involved [50]. Airway smooth muscle incubated
with an inhibitor of the p38 MAP kinase pathway demon-
strates a greater degree of fluctuation-driven muscle
lengthening than does control muscle, and upon removal
of the force fluctuations it remains at a greater length.
Moreover, force fluctuations themselves activate the p38
MAP kinase pathway. It is noteworthy in that connection
that heat shock protein 27 has been implicated as an
essential element in the motility of airway smooth muscle
cells and is a downstream target of rho and p38 [118,183-
187]. These findings are consistent with the hypothesis
that stress response pathways may somehow stabilize the
airway smooth muscle cytoskeleton and limit the bron-
chodilating effects of deep inspirations.
Regardless of the specific molecules and mechanisms
invoked to explain the plasticity of the contractile
response, the melting of the contractile domain would
appear to be a necessary (or permissive) event, but one
that by itself is not sufficient to explain the effects of the
history of tidal loading. This brings us, finally, to the
notion of the cytoskeleton acting as a glassy material.
An emerging question: are we built of glass?
The abilities of the cytoskeleton (CSK) to deform, to flow,
and to remodel (i.e., mechanical plasticity) come into
play in a wide variety of situations, from cell division,
crawling and extravasation to invasion, contraction and
wound healing.
Deformation, flow and remodeling of the airway smooth
muscle cell can be described at the molecular level by spe-
cific modes of molecular motion and interactions
between specific molecular species, at least in principle.
The straight-forward approach would be to use direct
numerical simulation to describe these molecular interac-
tions within an integrated cytoskeletal lattice and then go
on to compute the macroscale integrative properties that
result. Direct numerical simulation faces three daunting
problems, however. The first is shear complexity; the
number of cytoskeletal molecular species is counted in the
scores. Moreover, integrated multi-molecular assemblies
in airway smooth muscle comprise a messy microstruc-
tural geometry, one characterized by a degree of long
range order that is far less than that observed in ordinary
solids but far greater than that found in fluids. The second
is that the list of species remains incomplete and the
nature of most protein-protein interactions has yet to be
characterized biophysically, with the acto-myosin interac-
tion being the exception that proves the rule. And third,
there is good evidence to suggest that in several regards
these systems exist far away from local thermodynamic
equilibrium (LTE); elemental components do not enjoy a
fixed spatial address and, instead, are closely packed and
continuously jostling one another in a never-ending
search for a minimum energy configuration but never
managing to find one. Accordingly, these configurations
are adaptable, being in a continuous state of remodeling
and, in the process, consuming energy on an ongoing
basis via the hydrolysis of ATP. If the first two problems
are not enough to saturate the most powerful present-day
computers, the non-LTE nature of the problem is particu-
larly thorny because it adds a crucial dimension to the
biophysics at the same time that it invalidates a major
class of computational approaches, namely, those based
on principles of energy minimization.
All three problems are addressed by the approach of Fabry
et al. [[187,189]. Using airway smooth muscle cells in a
culture system, Fabry discovered that integrative statistical
properties of the cytoskeleton, such as measures of its abil-
ity to deform, to flow and to remodel, conform at the
macroscale to a universal empirical framework, namely,
that of glassy systems. Findings to date suggest that these
processes depend mainly on a putative energy level in the
cytoskeletal lattice, where that energy is representative of
the amount of molecular agitation, or jostling, present in
the lattice relative to the depth of energy wells that con-
strain molecular motions. This energy level can be
expressed as an effective lattice temperature – as distinct
from the familiar thermodynamic temperature. Even
while the thermodynamic temperature is held fixed thisRespiratory Research 2004, 5 http://respiratory-research.com/content/5/1/2
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effective temperature can change, can be manipulated,
and can be measured. The higher the effective tempera-
ture, the more frequently do elemental structures trapped
in one energy well manage to hop out of that well only to
fall into another. The hop, therefore, can be thought of as
the fundamental molecular remodeling event.
Among the many consequences of these findings, one can
easily show that the rate of cytoskeletal remodeling (plas-
tic adaptation) must scale as this effective temperature;
when the matrix is "hot", as it is early an a contractile
event for example, the rate of remodeling can be fast. But
later in the contractile event, as the effective temperature
falls and the matrix "cools", the rate of remodeling slows
[188-190]. If the effective temperature falls enough that
remodeling virtually comes to a standstill, the matrix
behaves as if it were frozen. This latter state is consistent
with and subsumes the latch state, as described above,
while load fluctuations driven by the action of breathing
impinge on the cell and represent another source of agita-
tion whose action is consistent with an elevated effective
temperature [[187,189]: Gunst, 2003 #1051]. Taken
together, these features describe a soft glass, and the effec-
tive temperature at which all remodeling ceases is called
the glass transition temperature. Data available to date
conform in many ways to predictions based upon the idea
of traps and hops, and conform as well to closely similar
behavior that is shared by other soft materials found in
nature including foams, pastes, slurries, colloids and
some clays. Taken together, these are referred to in the lit-
erature as the class of soft glassy materials.
Future directions
It has become well established that muscle length is equil-
ibrated dynamically rather than statically, and that in a
dynamic micro-environment non-classical features of
muscle biophysics come to the forefront, including unan-
ticipated interactions between the muscle and its time-
varying load, as well as the ability of the muscle cell to
adapt rapidly to changes in its mechanical
microenvironment. Evidence supporting the notion of a
highly malleable cell is accumulating rapidly, but a mech-
anistic basis to explain this malleability is only beginning
to emerge. The notion that airway smooth muscle malle-
ability and remodeling might be explained as a reflection
of glassy behavior in the neighborhood of a glass transi-
tion is attractive because it is rather simple yet seems to tie
together diverse behaviors within a unified empirical
framework [188-190]. But whether this line of thinking
will bear fruit remains to be seen.
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